Petco Health & Wellness Company, Inc. current report, 30 November 2022

Petco Health & Wellness Company, Inc. — Form 8-K Summary

Business context and reporting period

Petco filed this Current Report on November 30, 2022, under Items 2.02, 7.01, and 9.01. The filing announced the release of financial results for the quarter ended October 29, 2022. The filing identifies the company’s Class A common stock as trading under the symbol WOOF on Nasdaq.

Financial metrics and operating results

The filing states that a press release containing quarterly financial results was issued and attached as Exhibit 99.1. The provided filing text does not include the press release’s revenue, profit, cash flow, margins, debt, liquidity, or other financial figures.

Material changes versus the prior comparable period

The filing text does not provide the underlying quarterly results or comparative period figures, so material changes cannot be assessed from the available content.

Guidance, outlook, commentary, risks, and unusual items

  • The company scheduled an earnings webcast for 8:30 a.m. Eastern Time on November 30, 2022, to discuss the quarter’s results.
  • An earnings presentation and infographic were to be posted on Petco’s investor relations website.
  • A webcast replay was expected to remain available through approximately 5:00 p.m. Eastern Time on December 14, 2022.
  • The filing text does not provide guidance, management commentary, risk updates, contingencies, or unusual items.
  • The results and Regulation FD information were furnished rather than filed for purposes of Section 18 liability and generally were not incorporated by reference into other filings unless expressly referenced.

Investor verification points

  • Review Exhibit 99.1 for the complete quarterly financial results and comparative metrics.
  • Verify any guidance updates, operating trends, liquidity information, debt balances, and management commentary in the attached press release and earnings materials.
  • Confirm whether the webcast or presentation disclosed risks, contingencies, non-GAAP measures, or unusual items not included in this Form 8-K text.